Prior information for population pharmacokinetic and pharmacokinetic/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine.


Journal

Journal of pharmacokinetics and pharmacodynamics
ISSN: 1573-8744
Titre abrégé: J Pharmacokinet Pharmacodyn
Pays: United States
ID NLM: 101096520

Informations de publication

Date de publication:
10 2020
Historique:
received: 27 01 2020
accepted: 08 06 2020
pubmed: 15 6 2020
medline: 21 9 2021
entrez: 15 6 2020
Statut: ppublish

Résumé

Population pharmacokinetic analysis is used to estimate pharmacokinetic parameters and their variability from concentration data. Due to data sparseness issues, available datasets often do not allow the estimation of all parameters of the suitable model. The PRIOR subroutine in NONMEM supports the estimation of some or all parameters with values from previous models, as an alternative to fixing them or adding data to the dataset. From a literature review, the best practices were compiled to provide a practical guidance for the use of the PRIOR subroutine in NONMEM. Thirty-three articles reported the use of the PRIOR subroutine in NONMEM, mostly in special populations. This approach allowed fast, stable and satisfying modelling. The guidance provides general advice on how to select the most appropriate reference model when there are several previous models available, and to implement and weight the selected parameter values in the PRIOR function. On the model built with PRIOR, the similarity of estimates with the ones of the reference model and the sensitivity of the model to the PRIOR values should be checked. Covariates could be implemented a priori (from the reference model) or a posteriori, only on parameters estimated without prior (search for new covariates).

Identifiants

pubmed: 32535847
doi: 10.1007/s10928-020-09695-z
pii: 10.1007/s10928-020-09695-z
pmc: PMC7520416
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-446

Références

Antimicrob Agents Chemother. 2020 Feb 21;64(3):
pubmed: 31844002
J Pharmacokinet Pharmacodyn. 2007 Feb;34(1):35-55
pubmed: 17004125
J Clin Pharmacol. 2013 May;53(5):505-16
pubmed: 23381936
J Pharmacokinet Pharmacodyn. 2002 Dec;29(5-6):473-505
pubmed: 12795242
Clin Pharmacol Ther. 2010 Mar;87(3):294-302
pubmed: 20107435
Br J Clin Pharmacol. 2019 Aug;85(8):1808-1819
pubmed: 31026084
Clin Pharmacokinet. 2006;45(2):177-97
pubmed: 16485916
Br J Clin Pharmacol. 2016 Dec;82(6):1517-1527
pubmed: 27447545
Clin Pharmacokinet. 2017 Apr;56(4):421-433
pubmed: 27743205
Cancer Chemother Pharmacol. 2012 May;69(5):1155-63
pubmed: 22212298
Pharmacogenomics. 2019 Mar;20(4):225-240
pubmed: 30767706
Antimicrob Agents Chemother. 2012 Sep;56(9):4927-36
pubmed: 22802243
CPT Pharmacometrics Syst Pharmacol. 2019 May 1;:
pubmed: 31044558
Int J Antimicrob Agents. 2017 Feb;49(2):212-217
pubmed: 28038962
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30038039
J Pharmacokinet Pharmacodyn. 2017 Dec;44(6):509-520
pubmed: 28887735
J Pharmacokinet Pharmacodyn. 2013 Apr;40(2):129-42
pubmed: 23307170
Br J Clin Pharmacol. 2012 Sep;74(3):525-35
pubmed: 22300419
J Pharmacokinet Pharmacodyn. 2017 Apr;44(2):69-79
pubmed: 27578330
J Biopharm Stat. 2008;18(4):662-76
pubmed: 18607800
Eur J Pharm Sci. 2016 Sep 20;92:117-30
pubmed: 27373670
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):463-77
pubmed: 22791078
Antimicrob Agents Chemother. 2015;59(6):3216-23
pubmed: 25801557
J Med Biochem. 2019 May 11;38(3):323-331
pubmed: 31156343
AAPS J. 2017 Jan;19(1):223-233
pubmed: 27739011
Br J Clin Pharmacol. 2016 Aug;82(2):399-411
pubmed: 27096250
Pharm Res. 2015 Jun;32(6):1864-83
pubmed: 25446771
Malar J. 2018 Mar 23;17(1):126
pubmed: 29566683
PLoS One. 2015 Oct 26;10(10):e0141002
pubmed: 26501782
Curr Ther Res Clin Exp. 2017 Apr 10;84:42-49
pubmed: 28761579
Clin Pharmacokinet. 2019 Dec;58(12):1621-1634
pubmed: 31209657
Nat Commun. 2019 Jan 29;10(1):480
pubmed: 30696903
CPT Pharmacometrics Syst Pharmacol. 2016 Dec;5(12):692-700
pubmed: 28028939
Pharm Res. 2014 Dec;31(12):3390-403
pubmed: 24919931
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061282
Eur J Clin Pharmacol. 2007 May;63(5):485-98
pubmed: 17345074

Auteurs

Anna H-X P Chan Kwong (AHP)

Pharmacokinetic and Modeling Department, School of Pharmacy, Montpellier University, Montpellier, France. anna.chankwong@gmail.com.
Probabilities and Statistics Department, Institut Montpelliérain Alexander Grothendieck (IMAG), UMR 5149, CNRS, Montpellier University, Montpellier, France. anna.chankwong@gmail.com.
SMARTc group, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Aix-Marseille University, Marseille, France. anna.chankwong@gmail.com.
Pharmacokinetics-Dynamics and Metabolism (PKDM), Sanofi R&D, Translational Medicine and Early Development, Montpellier, France. anna.chankwong@gmail.com.

Elisa A M Calvier (EAM)

Pharmacokinetics-Dynamics and Metabolism (PKDM), Sanofi R&D, Translational Medicine and Early Development, Montpellier, France.

David Fabre (D)

Pharmacokinetics-Dynamics and Metabolism (PKDM), Sanofi R&D, Translational Medicine and Early Development, Montpellier, France.

Florence Gattacceca (F)

SMARTc group, Inserm, CNRS, Institut Paoli-Calmettes, CRCM, Aix-Marseille University, Marseille, France.

Sonia Khier (S)

Pharmacokinetic and Modeling Department, School of Pharmacy, Montpellier University, Montpellier, France.
Probabilities and Statistics Department, Institut Montpelliérain Alexander Grothendieck (IMAG), UMR 5149, CNRS, Montpellier University, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH